Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA and Aromatase Inhibitors in AR-positive Metastatic Breast Cancer
NCT02000375Phase 2Terminated
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
- Start
- Mar 2013
- Primary completion
- Feb 2016
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of dehydroepiandrosterone in breast cancer, sponsored by Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori". Started Mar 2013; status: terminated.
02
Drugs
dehydroepiandrosterone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02000375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02000375.